The c-myb proto-oncogene: a novel target for human gene therapy.
Gewirtz
A M
AM
University of Pennsylvania, School of Medicine, Department of Pathology, Philadelphia 19104-6082, USA.
D000818:Animals; D004268:DNA-Binding Proteins / Q000502:physiology*; D015316:Genetic Therapy; D006801:Humans; D008545:Melanoma / Q000628:therapy; D051379:Mice; D016513:Mice, SCID; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D014176:Protein Biosynthesis; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology*; D020598:Proto-Oncogene Proteins c-myb; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology*; D014158:Transcription, Genetic
D004268:DNA-Binding Proteins; C000715470:MAS1 protein, human; D016376:Oligonucleotides, Antisense; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D015534:Trans-Activators